Tower Research Capital LLC (TRC) - BELLEROPHON THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of BELLEROPHON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,840
-42.4%
7,135
-0.2%
0.00%
Q2 2023$4,934
+123250.0%
7,150
+1371.2%
0.00%
Q1 2023$4
-20.0%
486
-91.7%
0.00%
Q4 2022$5
-99.9%
5,872
-22.3%
0.00%
Q3 2022$8,000
-38.5%
7,561
-28.8%
0.00%
Q2 2022$13,000
+225.0%
10,625
+574.2%
0.00%
Q1 2022$4,000
+100.0%
1,576
+125.8%
0.00%
Q4 2021$2,000
-81.8%
698
-67.2%
0.00%
Q1 2021$11,000
+10.0%
2,131
+47.8%
0.00%
Q4 2020$10,000
-72.2%
1,442
-59.4%
0.00%
Q3 2020$36,000
+1700.0%
3,552
+1977.2%
0.00%
Q2 2020$2,0001710.00%
Other shareholders
BELLEROPHON THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Puissance Capital Management LP 1,153,846$14,481,00061.82%
Telemetry Investments, L.L.C. 125,000$1,569,0004.26%
NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. 1,009,231$12,666,0000.60%
Boxer Capital, LLC 98,809$1,240,0000.06%
RPg Family Wealth Advisory, LLC 3,000$37,650,0000.02%
DAVENPORT & Co LLC 107,150$1,345,0000.02%
TOCQUEVILLE ASSET MANAGEMENT L.P. 25,400$319,0000.01%
ExodusPoint Capital Management, LP 16,500$207,0000.01%
Renaissance Technologies 298,111$3,741,0000.00%
Financial Architects, Inc 200$3,0000.00%
View complete list of BELLEROPHON THERAPEUTICS INC shareholders